Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases
Objectives
To describe patients with autoimmune inflammatory rheumatic diseases (AIRD) who had COVID-19 disease; to compare patients who required hospital admission with those who did not and assess risk factors for hospital admission related to COVID-19.
Methods
An observational longitudinal study was conducted during the pandemic peak of severe acute respiratory syndrome coronavirus 2 (1 March 2020 to 24 April). All patients attended at the rheumatology outpatient clinic of a tertiary hospital in Madrid, Spain with a medical diagnosis of AIRD and with symptomatic COVID-19 were included. The main outcome was hospital admission related to COVID-19. The covariates were sociodemographic, clinical and treatments. We ran a multivariable logistic regression model to assess risk factors for the hospital admission.
Results
The study population included 123 patients with AIRD and COVID-19. Of these, 54 patients required hospital admission related to COVID-19. The mean age on admission was 69.7 (15.7) years, and the median time from onset of symptoms to hospital admission was 5 (3–10) days. The median length of stay was 9 (6–14) days. A total of 12 patients died (22%) during admission. Compared with outpatients, the factors independently associated with hospital admission were older age (OR: 1.08; p=0.00) and autoimmune systemic condition (vs chronic inflammatory arthritis) (OR: 3.55; p=0.01). No statistically significant findings for exposure to disease-modifying antirheumatic drugs were found in the final model.
Conclusion
Our results suggest that age and having a systemic autoimmune condition increased the risk of hospital admission, whereas disease-modifying antirheumatic drugs were not associated with hospital admission.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
Clinical Rheumatology
6 publications, 5.71%
|
|
|
Rheumatology
5 publications, 4.76%
|
|
|
Rheumatology International
4 publications, 3.81%
|
|
|
Frontiers in Immunology
3 publications, 2.86%
|
|
|
BMC Rheumatology
3 publications, 2.86%
|
|
|
Journal of Autoimmunity
3 publications, 2.86%
|
|
|
Rheumatology Advances in Practice
3 publications, 2.86%
|
|
|
Journal of Clinical Rheumatology
2 publications, 1.9%
|
|
|
Therapeutic Advances in Musculoskeletal Disease
2 publications, 1.9%
|
|
|
International Journal of Rheumatic Diseases
2 publications, 1.9%
|
|
|
Zeitschrift fur Rheumatologie
2 publications, 1.9%
|
|
|
Journal of Translational Autoimmunity
2 publications, 1.9%
|
|
|
Ophthalmology
2 publications, 1.9%
|
|
|
Nauchno-Prakticheskaya Revmatologiya
2 publications, 1.9%
|
|
|
Modern Rheumatology
2 publications, 1.9%
|
|
|
Current Rheumatology Reviews
1 publication, 0.95%
|
|
|
Current Pharmaceutical Design
1 publication, 0.95%
|
|
|
Journal of Oral Medicine and Oral Surgery
1 publication, 0.95%
|
|
|
Journal of Clinical Immunology
1 publication, 0.95%
|
|
|
World Journal of Methodology
1 publication, 0.95%
|
|
|
Nihon Naika Gakkai Zasshi
1 publication, 0.95%
|
|
|
Lupus
1 publication, 0.95%
|
|
|
Journal of Clinical Medicine
1 publication, 0.95%
|
|
|
Antioxidants
1 publication, 0.95%
|
|
|
Pathogens
1 publication, 0.95%
|
|
|
Viruses
1 publication, 0.95%
|
|
|
Frontiers in Medicine
1 publication, 0.95%
|
|
|
Current Rheumatology Reports
1 publication, 0.95%
|
|
|
Reviews in Endocrine and Metabolic Disorders
1 publication, 0.95%
|
|
|
1
2
3
4
5
6
|
Publishers
|
5
10
15
20
25
30
|
|
|
Springer Nature
28 publications, 26.67%
|
|
|
Elsevier
20 publications, 19.05%
|
|
|
Oxford University Press
9 publications, 8.57%
|
|
|
SAGE
6 publications, 5.71%
|
|
|
MDPI
6 publications, 5.71%
|
|
|
Wiley
6 publications, 5.71%
|
|
|
Frontiers Media S.A.
4 publications, 3.81%
|
|
|
Taylor & Francis
4 publications, 3.81%
|
|
|
Bentham Science Publishers Ltd.
3 publications, 2.86%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.9%
|
|
|
Mediar Press
2 publications, 1.9%
|
|
|
EDP Sciences
1 publication, 0.95%
|
|
|
Baishideng Publishing Group
1 publication, 0.95%
|
|
|
Japanese Society of Internal Medicine
1 publication, 0.95%
|
|
|
The Egyptian Society for Joint Diseases and Arthritis
1 publication, 0.95%
|
|
|
Georg Thieme Verlag KG
1 publication, 0.95%
|
|
|
BMJ
1 publication, 0.95%
|
|
|
American Society for Microbiology
1 publication, 0.95%
|
|
|
Kemerovo State Medical University
1 publication, 0.95%
|
|
|
Korean Academy of Medical Sciences
1 publication, 0.95%
|
|
|
PAGEPress Publications
1 publication, 0.95%
|
|
|
Medknow
1 publication, 0.95%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 0.95%
|
|
|
5
10
15
20
25
30
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.